EHMT1 and Familial prostate cancer: Importantly, the enhanced cell proliferation or migration observed in the K450/451R mutant was blocked by EHMT1 inhibition (Fig. 4I and J), suggesting that catalytic activity of EHMT1 is required for the unmethylated form to promote prostate cancer progression.